LIDIA BERRONE: Open Payments
NPI 1467451930 · KETTERING, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,440 in 195 payments from 12 companies in 2025. Trend: 2023 $4,506 · 2024 $3,485 · 2025 $3,440
Food & beverage: $3,432Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 50 | $1,015 |
| ABBVIE INC. | 45 | $598 |
| E.R. Squibb & Sons, L.L.C. | 28 | $466 |
| Alkermes, Inc. | 19 | $344 |
| Lundbeck LLC | 25 | $320 |
| Teva Pharmaceuticals USA, Inc. | 3 | $223 |
| Vanda Pharmaceuticals Inc. | 11 | $208 |
| Axsome Therapeutics, Inc. | 9 | $172 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: REXULTI, VRAYLAR, COBENFY, ARISTADA, Auvelity, ABILIFY ASIMTUFII, HETLIOZ, LYBALVI.
Industry payments across OH — which companies pay providers there.
